Table 4.
Multivariate analysis of clinical factors for PFS and OS according to NLR.
| Characteristics | OS | PFS | ||||
|---|---|---|---|---|---|---|
| HR | 95%CI | P value | HR | 95%CI | P value | |
| B symptoms | 1.302 | 0.669-2.535 | 0.437 | 1.494 | 0.772-2.892 | 0.233 |
| ECOG PS (⩾2) | 0.690 | 0.213-2.237 | 0.537 | 0.661 | 0.204-2.146 | 0.491 |
| LDH (>ULN) | 1.701 | 0.720-4.015 | 0.046 | 1.879 | 0.807-4.377 | 0.044 |
| Stage (III and IV) | 0.700 | 0.297-1.649 | 0.415 | 0.697 | 0.295-1.648 | 0.411 |
| IPI (>2) | 1.326 | 0.743-2.366 | 0.039 | 1.223 | 0.685-2.181 | 0.046 |
| Extranodal sites of disease (>1) | 1.293 | 0.483-3.461 | 0.609 | 1.314 | 0.489-3.532 | 0.588 |
| NLR⩾150 | 1.564 | 0.853-2.867 | 0.148 | 1.527 | 0.830-2.809 | 0.173 |